
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
- Volume 4
- Issue 4 Suppl
Pravastatin Event Reduction Analysis
Author(s)James Shepherd, MD, PhD
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Coronary Heart Disease in the United Statesover 27 years ago
Mechanisms of Acute Coronary Eventsover 27 years ago
Primary Preventionover 27 years ago
Secondary Preventionover 27 years ago
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?over 27 years ago
Methods and Mindsets in Pharmacoeconomicsover 27 years ago
Issues and Controversies in Pharmacoeconomicsover 27 years ago
Pharmacoeconomics Perspectives: Payers, Providers, and PatientsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Survey Reveals Clinician Confidence Around Using AI in PA Process
3
How Medicaid Reforms Could Deepen State Coverage Gaps
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5